SUMMARY Forty patients presenting with first episode genital herpes were randomly allocated to seven day treatment with oral acyclovir alone, placebo alone, oral acyclovir plus co-trimoxazole, or placebo plus co-trimoxazole. Patients receiving acyclovir had significantly shorter periods of viral shedding (p<0001),pain (p=003), and times to lesion healing (p< O0O5).Averaged over all patients there was no evidence that co-trimoxazole affected any of the variables, though in women cotrimoxazole was associated with a shorter time to lesion healing (p<0-0l). Furthermore, the combination treatment gave significantly shorter times to lesion healing than acyclovir alone, placebo alone, or placebo and co-trimoxazole (p=O0O1) and good trends elsewhere (external lesions and duration of pain). Neither drug was associated with any adverse events or toxicity or influenced the subsequent recurrence rate.
Introduction
The number of patients with genital herpes attending clinics in the United Kingdom is rapidly increasing. First episodes are often severe, and their management may necessitate hospital admission. Until recently treatment was largely symptomatic and consisted primarily of providing adequate analgesia and control of secondary bacterial infection of lesions by frequent saline baths combined with systemic antibiotics. Cotrimoxazole, which does not interfere with investigations for syphilis, has often been the preferred antibiotic. Roy, however, was unable to show any appreciable effect on the duration of symptoms or time to healing produced by co-trimoxazole in first episode genital herpes. ' The introduction of acyclovir now offers effective antiviral treatment of genital herpes. Recent studies have shown antiviral activity producing clinical benefit when acyclovir has been administered either intravenously,2 topically,3 4or orally5 6 
Results

COMPARISONS OF TREATMENT GROUPS
Forty patients entered the study, but two were withdrawn from analysis because they failed to comply with the protocol. A total of 38 (18 men and 20 women) completed the study as planned, 10 of whom received acyclovir alone, 10 received placebo alone, nine received acyclovir plus co-trimoxazole, and nine received placebo plus co-trimoxazole. Table I compares the characteristics of the treatment groups at presentation. There were no significant differences between patients who received acyclovir or placebo, or between patients who were treated or not with co-trimoxazole.
Overall 29 (76%) patients had true primary infections. Positive viral cultures were obtained from * Includes all who received the drug named (acyclovir (n= 19), includes 10 patients who received acyclovir alone and nine who received acyclovir plus co-trimoxazole; placebo (n-19) includes 10 patients receiving placebo alone and nine receiving placebo plus co-trimoxazole;co-trimoxazole (n=18) includes nine patients receiving acyclovir plus co-trimoxazole and nine receiving placebo plus co-trimoxazole; and no co-trimoxazole (n=20) includes 10 patients receiving placebo alone and 10 receiving acyclovir alone).
group The relevance of antibacterial treatment to the management of first episode genital herpes in other geographical areas needs to be investigated further. It may only be of local importance as, though recent Sheffield studies have shown a high prevalence of Haemophilus ducreyi and other bacterial pathogens in herpetic ulcers, the results were not confirmed in studies elsewhere in the United Kingdom. 10-12 Nevertheless, the concomitant use of acyclovir and antibiotic treatment is likely to be ofbenefit in patients with first episode initial herpes living in areas where chancroid is endemic. It would also be interesting to study the respective efficacies of antiviral and antibiotic treatment in patients who present more than six days after the onset of their lesions. We suggest that, in future studies of antiviral treatment of genital herpes, the concomitant use of antibiotics should be recorded.
Neither acyclovir nor co-trimoxazole treatment, alone or in combination, appears to influence the recurrence rate of genital herpes. Our results confirm that the typing of the causative virus isolate is of greater prognostic significance, as recurrences were rare after HSV-1 first episodes but usual after HSV-2 first episodes.
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